Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Coronary Stents Market Growth Performance Trended Historically, And What Lies Ahead?

The size of the coronary stents market has expanded significantly over the past few years. The market is projected to increase from a worth of $11.06 billion in 2024 to $12.02 billion in 2025, maintaining a compound annual growth rate (CAGR) of 8.6%. The historical development of the market can be credited to the growing inclination towards less invasive procedures, spreading healthcare accessibility in upcoming markets, escalating healthcare spending, a rise in percutaneous coronary interventions and an expanding count of cardiologists.

What Is the Forecast for the Coronary Stents Market Size Through 2029?

The market size of coronary stents is anticipated to experience robust growth in the coming years, expanding to $16.5 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 8.3%. This growth projection for the forecast period can be ascribed to the growing prevalence of heart diseases, the aging demographic, heightened awareness of heart health, government support and funding, as well as a surge in lifestyle diseases. Key trends for this forecast period encompass advances in stent and imaging technologies, strategic collaborations and partnerships, innovative stent materials and the integration of digital health with technology.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18325&type=smp

What are the Key Market Players in Coronary Stents Market and How They’re Evolving?

Major companies operating in the coronary stents market are Abbott Laboratories, Medtronic Plc, Biosensors International Group Ltd., Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, W. L. Gore & Associates Inc., Cook Medical Inc., BIOTRONIK SE & Co. KG, Lepu Medical Technology (Beijing) Co. Ltd., Meril Life Sciences Pvt. Ltd, MicroPort Scientific Corporation, OrbusNeich, Asahi Intecc Co. Ltd., Sahajanand Medical Technologies Limited, Translumina GmbH, Stentys S.A., Sorin Group, InspireMD Inc., C. R. Bard Inc., AMG International GmbH, Svelte Medical Systems Inc., Zorion Medical Inc., Spectranetics Corporation

What Are the Primary Growth Drivers in the Coronary Stents Market?

The escalating occurrence of cardiovascular diseases (CVDs) is predicted to drive the expansion of the coronary stent market in the future. Cardiovascular diseases, which encompass disorders of the heart and blood vessels such as coronary artery disease, heart failure, stroke, and hypertension, are on the rise. Factors contributing to this growth include an ageing population, obesity, diabetes, inactive lifestyles, poor nutrition, and stress levels. A coronary stent, which aids in opening narrowed or blocked coronary arteries, thereby enhancing blood flow to the heart and diminishing the chance of heart attacks, is a crucial treatment for these diseases. For example, a study by the American College of Cardiology, a US-based non-profit medical association, forecasted in August 2022 a substantial uptick in cardiovascular risk factors in the US from 2025 to 2060. The number of diabetes cases is expected to grow by 39.3% to 55 million, dyslipidemia by 27.6% to 126 million, hypertension by 25.1% to 162 million, and obesity by 18.3% to 126 million. The largest expected increases in cardiovascular diseases are for stroke (33.8% increase to 15 million) and heart failure (33.4% increase to 13 million). These are closely followed by ischemic heart disease (30.7% increase to 29 million) and heart attacks (16.9% increase to 16 million). As such, the growing occurrence of cardiovascular diseases (CVDs) fuels the expansion of the coronary stent market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=18325&type=smp

What Are the Leading Segments in the Global Coronary Stents Industry?

The coronary stents market covered in this report is segmented –

1) By Product Type: Dual Therapy Stents, Radioactive Stents, Thrombectomy Stents, Covered Stents, Bioresorbable Stents, Biodegradable Stents, Hybrid Stents, Drug-Eluting Stents, Bare Metal Stents

2) By Technology: Laser Cutting, 3D-Printed Stents, Microfabrication, Nanotechnology-Based Stents, Electropolishing, Others Technologies

3) By Raw Material: Cobalt-Chromium, Stainless Steel, Platinum–Chromium, Nickel–Titanium, Polymer

4) By Deployment: Self-Expandable Stents, Balloon-Expandable Stents

5) By End Uses: Hospitals And Ambulatory Surgical Centers, Specialty Clinics, Other End Uses

Subsegments:

1) By Dual Therapy Stents: Sirolimus-Eluting Dual Therapy Stents, Paclitaxel-Eluting Dual Therapy Stents, Everolimus-Eluting Dual Therapy Stents

2) By Radioactive Stents: Beta Radiation Stents, Gamma Radiation Stents, Other Radiation Stents

3) By Thrombectomy Stents: Manual Thrombectomy Stents, Mechanical Thrombectomy Stents, Hydrodynamic Thrombectomy Stents

4) By Covered Stents: PTFE-Covered Stents, ePTFE-Covered Stents, Polyurethane-Covered Stents, Other Covered Stents

5) By Bioresorbable Stents: Polymer-Based Bioresorbable Stents, Metal-Based Bioresorbable Stents, Ceramic-Based Bioresorbable Stents

6) By Biodegradable Stents: Polymeric Biodegradable Stents, Magnesium-Based Biodegradable Stents, Other Biodegradable Stents

7) By Hybrid Stents: Hybrid Drug-Eluting Stents, Hybrid Biodegradable Or Metal Stents, Other Hybrid Stents

8) By Drug-Eluting Stents: Sirolimus-Eluting Stents, Paclitaxel-Eluting Stents, Everolimus-Eluting Stents, Zotarolimus-Eluting Stents, Other Drug-Eluting Stents

9) By Bare Metal Stents: Stainless Steel Bare Metal Stents, Cobalt Chromium Bare Metal Stents, Other Bare Metal Stents

What Are the Key Market Trends in the Coronary Stents Industry?

Leading enterprises in the coronary stent market are pioneering novel products like drug-eluting stents to decrease the necessity for subsequent procedures in comparison to bare-metal stents. Drug-eluting stents are special coronary stents layered with medications that help prevent artery re-narrowing by slowly discharging drugs over a certain period. An example is Abbott, an American health firm, who introduced the XIENCE Sierra Everolimus (drug) Eluting Coronary Stent System in India in May 2024. The XIENCE Sierra stent is distinctive due to its improved design, innovative delivery system, and exclusive size choices. It’s specifically built to tackle difficult cases while maintaining the custom coating that curtails the likelihood of artery re-obstruction, just like other XIENCE stents. Over 120 clinical trials involving more than 120,000 individuals back this stent’s superb safety history.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/coronary-stents-global-market-report

What Is the Regional Outlook for the Coronary Stents Market?

North America was the largest region in the coronary stents market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the coronary stents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18325

This Report Delivers Insight On:

1. How big is the coronary stents market, and how is it changing globally?

2. Who are the major companies in the coronary stents market, and how are they performing?

3. What are the key opportunities and risks in the coronary stents market right now?

4. Which products or customer segments are growing the most in the coronary stents market?

5. What factors are helping or slowing down the growth of the coronary stents market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model